News + Filings Transactions
|
McAnear Justin J.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/22/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.7k | $45.78 | $76.8k | | 08/22/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 194 | $55.07 | $10.7k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 465 | $55.06 | $25.6k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 441 | $55.06 | $24.3k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 565 | $55.06 | $31.1k | | 05/23/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 26k | $0.00 | $0 | | 03/21/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Stock Option (right to buy) | 26k | $50.10 | $1.3M | | 03/21/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Performance based Restricted Stock Units | 13k | $0.00 | $0 | | 03/21/2023 |
| 02/22/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.2k | $47.75 | $59.5k | | 02/22/2023 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 686 | $34.07 | $23.4k | | 11/22/2022 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 652 | $34.07 | $22.2k | | 11/22/2022 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 288 | $34.07 | $9.8k | | 11/22/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 20.3k | $0.00 | $0 | | 09/14/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Stock Option (right to buy) | 40.6k | $33.67 | $1.4M | | 09/14/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Performance-based Restricted Stock Units | 40.6k | $0.00 | $0 | | 09/14/2022 |
| 08/23/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 987 | $35.19 | $34.7k | | 08/23/2022 |
| 05/23/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 967 | $48.76 | $47.2k | | 05/23/2022 |
| 05/13/2022 | 10x Genomics, Inc. | TXG | Purchase | Class A Common Stock | 158 | $40.49 | $6.4k | | 05/13/2022 |
| 03/22/2022 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 21.4k | $0.00 | $0 | | 03/22/2022 |
| 03/22/2022 | 10x Genomics, Inc. | TXG | Grant | Stock Option (Right to Buy) | 53.4k | $69.56 | $3.7M | | 03/22/2022 |
| 02/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 288 | $78.60 | $22.6k | | 02/22/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 3.6k | $145.16 | $520.1k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 4.1k | $145.96 | $595.9k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.3k | $146.92 | $196k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 500 | $148.04 | $74k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 500 | $149.18 | $74.6k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Exercise | Stock Option (right to buy) | 10k | $5.04 | $50.4k | | 01/03/2022 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.5k | $146.49 | $225k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 2.7k | $147.62 | $398.6k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.3k | $148.48 | $193.3k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 600 | $149.41 | $89.6k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 500 | $150.71 | $75.4k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 300 | $151.31 | $45.4k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 300 | $151.80 | $45.5k | | 12/01/2021 |
| 12/01/2021 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 200 | $153.86 | $30.8k | | 12/01/2021 |
|
|